The Current Ratio as of November 2024 (TTM) for Nexalin Technology, Inc. (NXL) is 16.39

According to Nexalin Technology, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 16.39. This represents a change of 86.89% compared to the average of 8.77 of the last 4 quarters.

Nexalin Technology, Inc. (NXL) Historical Current Ratio (quarterly & annually)

How has NXL Current Ratio performed in the past?

The mean historical Current Ratio of Nexalin Technology, Inc. over the last ten years is 2.47. The current 16.39 Current Ratio has changed 66.13% with respect to the historical average. Over the past ten years (40 quarters), NXL's Current Ratio was at its highest in in the September 2024 quarter at 16.39. The Current Ratio was at its lowest in in the March 2020 quarter at 0.

Nexalin Technology, Inc. (NXL) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Nexalin Technology, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Nexalin Technology, Inc. (NXL) Average Current Ratio

How has NXL Current Ratio performed in the past?

The current Current Ratio of Nexalin Technology, Inc. (NXL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Nexalin Technology, Inc. (NXL) Current Ratio vs. Peers

How is NXL’s Current Ratio compared to its peers?

Nexalin Technology, Inc.’s Current Ratio is greater than Ainos, Inc. (1.37), greater than Electromed, Inc. (5.53), less than Armm Inc. (0), greater than Surmodics, Inc. (3.96), greater than Bluejay Diagnostics, Inc. (6.26), greater than INVO Bioscience, Inc. (0.30), greater than Motus GI Holdings, Inc. (1.74), greater than IRIDEX Corporation (1.54), greater than Aziyo Biologics, Inc. (0.87), greater than Ainos, Inc. (1.37), greater than LENSAR, Inc. (3.37), greater than ProSomnus, Inc. Common Stock (0.30), greater than LivaNova PLC (3.37), greater than OrthoPediatrics Corp. (7.17), greater than Modular Medical, Inc. (3.36), greater than NeuroPace, Inc. (5.59), greater than STRATA Skin Sciences, Inc. (1.13), greater than Nemaura Medical Inc. (0.19),

Build a custom stock screener for Nexalin Technology, Inc. (NXL) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Nexalin Technology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Nexalin Technology, Inc. (NXL) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Nexalin Technology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.